111 related articles for article (PubMed ID: 10881680)
1. Can HCV affect the efficacy of anti-HIV treatment?
Filippini P; Coppola N; Scolastico C; Liorre G; Nocera R; Sagnelli E; Piccinino F
Arch Virol; 2000; 145(5):937-44. PubMed ID: 10881680
[TBL] [Abstract][Full Text] [Related]
2. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
4. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
5. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.
Chung RT; Evans SR; Yang Y; Theodore D; Valdez H; Clark R; Shikuma C; Nevin T; Sherman KE;
AIDS; 2002 Sep; 16(14):1915-23. PubMed ID: 12351951
[TBL] [Abstract][Full Text] [Related]
6. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
[TBL] [Abstract][Full Text] [Related]
7. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
8. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects.
Zylberberg H; Chaix ML; Rabian C; Rouzioux C; Aulong B; Bréchot C; Viard JP; Pol S
Clin Infect Dis; 1998 May; 26(5):1104-6. PubMed ID: 9597236
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis C virus coinfection on HAART in HIV-infected individuals: multicentric observation cohort.
Fuping G; Wei L; Yang H; Zhifeng Q; Lingyan Z; Yanling L; Taisheng L
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):137-42. PubMed ID: 20431395
[TBL] [Abstract][Full Text] [Related]
12. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.
Yokozaki S; Takamatsu J; Nakano I; Katano Y; Toyoda H; Hayashi K; Hayakawa T; Fukuda Y
Blood; 2000 Dec; 96(13):4293-9. PubMed ID: 11110704
[TBL] [Abstract][Full Text] [Related]
13. Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?
Gavazzi G; Bouchard O; Leclercq P; Morel-Baccard C; Bosseray A; Dutertre N; Micoud M; Morand P
AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1021-3. PubMed ID: 10933615
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
15. Liver enzymes elevation after HAART in HIV-HCV co-infection.
Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.
Yacisin K; Maida I; Ríos MJ; Soriano V; Núñez M
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):935-40. PubMed ID: 18593347
[TBL] [Abstract][Full Text] [Related]
17. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
18. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.
Tsiara CG; Nikolopoulos GK; Dimou NL; Bagos PG; Saroglou G; Velonakis E; Hatzakis A
J Viral Hepat; 2013 Oct; 20(10):715-24. PubMed ID: 24010646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
